The gut microbiome and mitochondrial function in metabolism, immunity, and disease.

The gut microbiome is a key regulator of host physiology, yet its effects remain difficult to predict across individuals and contexts. Similar microbial compositions frequently give rise to divergent and delayed phenotypic outcomes, indicating that models based solely on signal strength or steady-state responses are insufficient to explain microbiome-driven host function. In this review, we propose a conceptual perspective in which microbiome-associated variability is shaped by the capacity of host cells to maintain mitochondrial function under persistent metabolic and immune stress. Microbiome-derived metabolites and immune activity define the metabolic and redox environments that constrain mitochondrial performance, thereby influencing how effectively cells recover from repeated stress. When mitochondrial membrane potential, redox balance, and energy production are not fully restored, mitochondria may show increased engagement of quality-control pathways. Over repeated stress-recovery cycles, this pattern may be associated with reduced functional reserve despite preserved baseline activity. This testable perspective may help explain why microbiome-associated phenotypes are delayed, variable, and context-dependent, and it highlights mitochondrial recovery capacity as a potential determinant of disease vulnerability and host-microbiome interactions.